Study validates prediction model to differentiate chronic pancreatitis vs healthy cohort

Investigators identified and validated a human blood-metabolome prediction model that distinguished between patients with chronic pancreatitis and healthy individuals.“Whether this biomarker has clinical value for diagnosing early stages of [chronic pancreatitis (CP)] or can be used to monitor disease progression needs further prospective studies,” M. Gordian Adam, MD, from the Metanomics Health GmbH, Berlin, Germany, and colleagues wrote in Gut.Adam and colleagues performed a type 3 study to predict individual prognosis of chronic pancreatitis in 670 patients based on transparentRead More

Share on facebook
Share on twitter
Share on linkedin